Drugs Containing Excipient (Inactive Ingredient) ISOSTEARYL ALCOHOL

Generic drugs containing ISOSTEARYL ALCOHOL excipient

Company	Ingredient	NDC	Excipient
E Fougera & Co a division of Fougera Pharmaceuticals Inc	clindamycin phosphate	0168-0203	ISOSTEARYL ALCOHOL
NORTHSTAR RX LLC	clindamycin phosphate	16714-246	ISOSTEARYL ALCOHOL
Encube Ethicals Inc	clindamycin phosphate	21922-036	ISOSTEARYL ALCOHOL
Padagis Israel Pharmaceuticals Ltd	clindamycin phosphate	45802-128	ISOSTEARYL ALCOHOL

Isostearyl Alcohol Market Dynamics and Financial Trajectory

Last updated: August 7, 2026

Isostearyl alcohol is a specialty branched-chain fatty alcohol used primarily as an emollient, skin-conditioning agent, solvent, and formulation aid. Its commercial value is tied to cosmetics, topical pharmaceuticals, personal care, and specialty formulations rather than to a standalone pharmaceutical market.

The product has low regulatory exclusivity risk, limited patent protection at the molecule level, and moderate manufacturing barriers. Financial performance depends on feedstock costs, production scale, supplier qualification, regional capacity, and demand for premium sensory ingredients. Public companies generally do not report isostearyl alcohol revenue separately, so the market lacks a verifiable standalone revenue series.

What is isostearyl alcohol and how is it used?

Isostearyl alcohol is a branched C18 fatty alcohol, commonly identified by CAS Registry Number 27458-93-1. It is chemically distinct from straight-chain stearyl alcohol because branching lowers crystallinity and improves spreadability, lubricity, and skin feel. Commercial material is generally supplied as a mixture of branched-chain alcohol isomers rather than as a single stereochemically defined compound.

Attribute	Isostearyl alcohol
Chemical class	Branched fatty alcohol
Common CAS number	27458-93-1
Typical carbon chain	C18
Physical role	Emollient, solvent, skin-conditioning agent
Main applications	Topical creams, lotions, ointments, color cosmetics, hair care
Pharmaceutical status	Excipient or formulation component, not an active pharmaceutical ingredient
Primary market	Cosmetics and personal care
Supply model	Specialty chemical and oleochemical manufacturers
Principal commercial risks	Feedstock volatility, qualification requirements, supply concentration, regulatory documentation

The ingredient is valued for its low-grease sensory profile, lubricity, compatibility with oils and waxes, and ability to improve the texture of creams and topical dosage forms. It can also contribute to viscosity and emulsion stability when combined with surfactants, esters, waxes, or other fatty alcohols.

CosIng identifies isostearyl alcohol as a cosmetic ingredient with functions including emollient and skin conditioning. The European database does not make the substance an approved therapeutic active ingredient, but it supports its role in regulated cosmetic formulations (European Commission, n.d.).

What are the main pharmaceutical and healthcare applications?

Isostearyl alcohol is most relevant to nonsterile topical products. Its commercial use in pharmaceuticals is narrower than its use in personal care.

Topical dosage forms

Potential pharmaceutical applications include:

• Creams and lotions
• Ointments and semi-solid dermatological products
• Topical analgesics
• Dermatology products
• Barrier creams
• Transdermal and dermal delivery systems
• Cosmetic-drug combination products

The ingredient can improve skin feel and spreadability while functioning as an oil-phase component. In some formulations, it can replace or supplement mineral oil, petrolatum, cetyl alcohol, stearyl alcohol, or synthetic esters.

Oral, injectable, and ophthalmic products

Isostearyl alcohol has limited strategic relevance in oral solid dosage forms and little apparent relevance to injectable products. Its hydrophobicity, formulation role, and sensory profile support topical use more strongly than parenteral or aqueous oral formulations.

The FDA Inactive Ingredient Database is the principal public reference for identifying excipients used in FDA-approved drug products. A product-specific regulatory assessment must verify the exact substance name, route, dosage form, and maximum potency in the current database (U.S. Food and Drug Administration, n.d.-a).

How large is the isostearyl alcohol market?

No authoritative public source reports a standalone global market size for isostearyl alcohol. Market research firms generally place the ingredient within broader categories such as fatty alcohols, emollients, cosmetic ingredients, specialty oleochemicals, or pharmaceutical excipients.

The relevant market layers are:

Market layer	Relevance to isostearyl alcohol	Data quality
Global fatty alcohols	Direct upstream category	Generally available
Specialty emollients	Strong application overlap	Partially available
Cosmetic ingredients	Main demand pool	Available through industry estimates
Pharmaceutical excipients	Smaller application pool	Available at aggregate level
Isostearyl alcohol	Exact product market	Limited public disclosure

The commercial implication is important: broad market growth figures for fatty alcohols or cosmetic ingredients cannot be transferred directly to isostearyl alcohol. Isostearyl alcohol occupies a specialty niche with different pricing, qualification, and margin characteristics from commodity lauryl, cetyl, or stearyl alcohols.

What drives demand for isostearyl alcohol?

Demand is driven by formulation performance rather than by active-ingredient innovation.

Premium skin-care growth

Premium creams, facial products, sunscreens, and color cosmetics increasingly use differentiated emollients to improve spreadability, after-feel, and product texture. Isostearyl alcohol benefits when formulators replace heavier or more occlusive ingredients with branched, sensory-optimized materials.

Topical pharmaceutical outsourcing

Contract development and manufacturing organizations continue to develop semi-solid products for dermatology and consumer health. Each approved formulation creates supplier qualification requirements and switching costs, even when the excipient itself is not patented.

Silicone and mineral-oil substitution

Regulatory, marketing, and consumer preferences can create demand for alternative emollients. Isostearyl alcohol may be used in formulations seeking a different sensory profile from silicones, petrolatum, or conventional fatty alcohols.

Regional personal-care production

Asia-Pacific is the most important demand region for many specialty cosmetic ingredients because of its manufacturing base in China, Japan, South Korea, and Southeast Asia. Europe remains influential in ingredient compliance and sustainability standards. North America has a significant market for dermatology, OTC topical products, and premium personal care.

What is the financial trajectory for isostearyl alcohol?

The financial trajectory is likely to be stable-to-growing in nominal terms, with periodic margin pressure from feedstock and energy costs. There is no public basis for treating isostearyl alcohol as a high-growth pharmaceutical product comparable to a branded drug or biologic.

Revenue model

Supplier economics usually follow this structure:

1. Oleochemical or synthetic feedstock procurement
2. Branching, hydrogenation, separation, or purification
3. Quality-control testing
4. Packaging and regional distribution
5. Technical support and regulatory documentation

Specialty-grade suppliers can obtain higher prices than commodity fatty-alcohol producers because customers pay for consistency, odor control, color, impurity limits, documentation, and supply reliability. The margin premium depends on whether the product is sold as a standard cosmetic raw material or as a qualified pharmaceutical-grade excipient.

Public-company exposure

Large ingredient companies generally report results by business segment rather than by individual excipient. Croda reports broad business areas such as Consumer Care and Life Sciences, while BASF reports Care Chemicals and related segments. These disclosures establish exposure to cosmetic ingredients, excipients, and specialty chemicals, but they do not isolate isostearyl alcohol revenue (BASF, 2024; Croda International Plc, 2024).

Financial variable	Expected impact on isostearyl alcohol
C18 feedstock prices	Direct cost pressure
Energy and hydrogen costs	Processing-cost pressure
Cosmetic demand	Primary volume driver
Pharmaceutical topical demand	Smaller but higher-value demand pool
Supplier qualification	Supports retention and pricing
China capacity	Can increase competitive pressure
Freight costs	Important for regional supply economics
Sustainability documentation	Can increase compliance costs and support premium pricing
Product standardization	Limits long-term pricing power

Base-case trajectory

The base case is moderate volume growth, stable demand from personal care, and gradual expansion in topical formulations. Revenue growth would likely come from higher formulation penetration and geographic expansion rather than from a sharp increase in unit pricing.

Downside scenario

Downside risks include:

• Substitution by esters, silicones, hydrogenated polyisobutene, or other branched emollients
• Lower discretionary spending on premium cosmetics
• Excess capacity in specialty oleochemicals
• Feedstock cost increases that suppliers cannot pass through
• Customer consolidation and tender-based procurement
• Regulatory or sustainability restrictions on the raw-material chain

Upside scenario

Upside potential comes from:

• New dermatology and OTC topical formulations
• Replacement of mineral oil or silicones in selected products
• Higher use of sensory emollients in premium skin care
• Pharmaceutical-grade supplier qualification
• Growth in regional contract manufacturing
• Improved access to Asian and Latin American markets

What patents protect isostearyl alcohol?

The isostearyl alcohol molecule itself has limited patent value because it is an established fatty alcohol composition rather than a new drug substance. The strongest intellectual-property opportunities are usually formulation-specific or process-specific.

Composition and manufacturing patents

Potential patent categories include:

• Processes for producing branched fatty alcohol mixtures
• Feedstock conversion and hydrogenation methods
• Purification processes
• Isomer distribution control
• Low-odor or low-color grades
• Narrow impurity specifications
• Formulations containing isostearyl alcohol and active ingredients

A supplier may protect manufacturing know-how through trade secrets rather than patents. Process conditions, catalyst systems, purification sequences, and quality-control methods can be commercially important even where the final ingredient is old.

Formulation patents

Formulation patents may cover a topical composition containing isostearyl alcohol with:

• A dermatological active
• A particular emulsifier system
• A controlled-release system
• A defined oil-to-water ratio
• A specified particle or droplet size
• A particular stability profile
• A cosmetic sensory performance claim

Such patents generally protect the finished product or formulation architecture, not the excipient as a standalone chemical.

When does isostearyl alcohol lose exclusivity?

Isostearyl alcohol does not have a drug-style exclusivity period. It is an established chemical ingredient available from multiple suppliers, subject to applicable chemical, cosmetic, and pharmaceutical quality rules.

There is no standard Hatch-Waxman exclusivity clock for the ingredient. A formulation sponsor may have patents covering a particular product, but the expiration of those patents does not prevent continued sale of isostearyl alcohol for other uses.

Exclusivity category	Applicability
New chemical entity exclusivity	Not applicable
Orphan-drug exclusivity	Not applicable to the excipient
Biologic exclusivity	Not applicable
FDA Orange Book listing	Not applicable to the standalone excipient
Paragraph IV challenge	Relevant only to an approved drug product with listed patents
Formulation patent	Potentially relevant
Manufacturing patent	Potentially relevant
Trade-secret protection	Potentially important

What is the Orange Book status of isostearyl alcohol?

Isostearyl alcohol does not have an Orange Book listing as a standalone pharmaceutical product. The Orange Book identifies approved drug products and certain patent and exclusivity information; it is not an ingredient registry for excipients (U.S. Food and Drug Administration, n.d.-b).

A drug containing isostearyl alcohol could appear in an approved product whose patents are listed in the Orange Book. In that situation, the listed patents would generally protect the drug product, dosage form, method of use, or formulation. They would not automatically create exclusivity over isostearyl alcohol supplied to other customers.

Which companies compete in the isostearyl alcohol supply chain?

Competition is likely fragmented across specialty oleochemical producers, cosmetic-ingredient suppliers, and distributors. Known commercial channels include specialty ingredient companies offering branched fatty alcohols and emollient systems, including Croda and regional suppliers serving Asian cosmetic manufacturers.

Public disclosures do not establish that any single company controls the global isostearyl alcohol market. The competitive variables are:

• Batch-to-batch consistency
• Documentation and regulatory support
• Pharmaceutical-grade quality systems
• Global distribution
• Lead time
• Packaging options
• Sustainability data
• Ability to provide samples and formulation support
• Customer qualification history

Supplier qualification is a stronger barrier than patent ownership. Once an excipient is incorporated into a regulated topical product, customers may resist switching because of stability, bioequivalence, revalidation, and change-control requirements.

What manufacturing and intellectual-property barriers exist?

Isostearyl alcohol is less difficult to manufacture than complex biologic excipients, but consistent specialty-grade production is not trivial.

Manufacturing barriers

Key barriers include:

• Reliable access to suitable C18 feedstocks
• Control of branching and isomer distribution
• Removal of odor-causing impurities
• Color control
• Reproducible melting and solidification behavior
• Compliance with customer specifications
• GMP-compatible documentation for pharmaceutical use
• Regional inventory and logistics

The product’s chemistry is mature, so process innovation may create cost or quality advantages without creating a durable patent monopoly.

Intellectual-property barriers

The most defensible IP positions are likely to involve:

• Proprietary production processes
• Specialty grades with defined impurity profiles
• Finished topical formulations
• Combination products
• Delivery systems
• Trade secrets and customer-specific specifications

Freedom-to-operate analysis should search patent families covering both "isostearyl alcohol" and broader terms such as "branched fatty alcohol," "iso-octadecanol," "topical composition," "dermal formulation," and "emollient composition."

What litigation and Paragraph IV risks affect the market?

No standalone Paragraph IV or Orange Book litigation risk attaches to isostearyl alcohol as an excipient. Paragraph IV litigation can arise only when a generic applicant challenges patents listed against an approved drug product that uses the ingredient.

The relevant litigation risks are therefore indirect:

• A generic entrant may design around a formulation patent
• An innovator may assert a method-of-use patent
• A supplier may dispute process or composition claims
• A customer may challenge exclusivity over a topical delivery system
• A regulatory change may force reformulation

Settlement agreements involving a branded topical product could delay generic entry without affecting the broader supply of isostearyl alcohol. Public information does not support treating the ingredient as a litigation-driven market.

How does isostearyl alcohol compare with competing emollients?

Ingredient class	Sensory profile	Typical commercial position	Main substitution risk
Isostearyl alcohol	Dry, spreadable, lubricious	Specialty emollient	Esters and synthetic branched hydrocarbons
Stearyl alcohol	Waxy, richer, more structuring	Commodity to mid-range	Branched alcohols and esters
Cetyl alcohol	Waxy, thickening, creamy	Widely available	Cetearyl alcohol and esters
Mineral oil	Occlusive, stable, low cost	Commodity	Silicone and ester systems
Isopropyl myristate	Light, fast-spreading	Standard cosmetic ester	Other light esters
Hydrogenated polyisobutene	Smooth, glossy, stable	Premium synthetic emollient	Esters and silicones
Dimethicone	Slip and barrier performance	Broad pharmaceutical and cosmetic use	Silicone-free systems

Isostearyl alcohol has a defensible position when formulators prioritize sensory performance and branched-chain chemistry. It is less competitive where low cost, maximum availability, or strong occlusivity is the primary requirement.

What generic entry risks exist for products containing isostearyl alcohol?

Generic entry risk depends on the finished product, not on the excipient. A topical drug may face:

• Formulation patent claims
• Method-of-use patents
• Device or delivery-system patents
• Clinical or bioequivalence requirements
• Product-specific exclusivity
• Manufacturing complexity
• Restricted access to reference-product data

The presence of isostearyl alcohol alone does not materially prevent generic entry. A generic manufacturer can typically use the same excipient, a pharmaceutically equivalent excipient, or a design-around ingredient if the applicable regulatory pathway permits it.

Key Takeaways

• Isostearyl alcohol is a specialty branched C18 fatty alcohol used mainly in cosmetics and topical formulations.
• It has no standalone drug exclusivity period and no Orange Book status as an excipient.
• Public companies do not separately report isostearyl alcohol revenue, preventing a verified standalone market-size or revenue forecast.
• Financial performance depends on cosmetic demand, topical pharmaceutical development, specialty-grade premiums, feedstock costs, and supplier qualification.
• Molecular patent protection is weak or limited because the ingredient is established. Process patents, formulation patents, and trade secrets are more relevant.
• Generic and Paragraph IV risks attach to finished drug products containing isostearyl alcohol, not to the excipient itself.
• The strongest commercial moat is likely manufacturing consistency, regulatory documentation, customer qualification, and supply reliability.
• The base-case outlook is moderate growth with pricing pressure from substitution and competing specialty emollients.

FAQs

Is isostearyl alcohol an active pharmaceutical ingredient?

No. It is generally used as an excipient, emollient, solvent, or skin-conditioning component. Its function is formulation-related rather than pharmacologically active.

Is isostearyl alcohol the same as stearyl alcohol?

No. Stearyl alcohol is primarily a straight-chain C18 fatty alcohol. Isostearyl alcohol is a branched-chain C18 fatty alcohol with different melting, spreading, and sensory properties.

Can isostearyl alcohol be used in FDA-approved topical drugs?

It can be used if the complete formulation complies with applicable FDA requirements and the ingredient is acceptable for the relevant route, dosage form, concentration, and product context. The FDA Inactive Ingredient Database is the relevant public reference.

Does isostearyl alcohol have a pharmaceutical-grade specification?

A supplier may offer material manufactured and documented for pharmaceutical use, but "pharmaceutical grade" is not a universal substitute for product-specific regulatory qualification. Customers must evaluate identity, purity, impurities, manufacturing controls, and change-control procedures.

Is isostearyl alcohol exposed to biosimilar competition?

No. Biosimilar competition applies to biological products. Isostearyl alcohol is a small-molecule excipient and has no biosimilar pathway.

References

1. BASF SE. (2024). Annual report 2023. https://www.basf.com
2. Croda International Plc. (2024). Annual report and accounts 2023. https://www.croda.com
3. European Commission. (n.d.). CosIng: Cosmetic ingredients and substances. https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database_en
4. National Center for Biotechnology Information. (n.d.). PubChem compound summary: Isostearyl alcohol. PubChem. https://pubchem.ncbi.nlm.nih.gov
5. U.S. Food and Drug Administration. (n.d.-a). Inactive Ingredient Database. https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm
6. U.S. Food and Drug Administration. (n.d.-b). Approved drug products with therapeutic equivalence evaluations, Orange Book. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book